Literature DB >> 6388952

Interactions affecting drug absorption.

P G Welling.   

Abstract

The influence of drug-drug and drug-food interactions affecting the absorption of orally administered medication is reviewed. Drug-drug interactions can be classified in terms of indirect effects by one drug on gastrointestinal tract physiology influencing the absorption of other drugs, or direct interactions involving altered pH, adsorption, absorption, or chelation. Most, but not all, drug-drug interactions result in reduced or delayed systemic drug availability. Drug-food interactions may result in reduced, delayed, or increased systemic drug availability. The absorption of only a small number of drugs is unaffected by concomitant food intake. The degree of interaction and whether it positively or negatively affects drug absorption depends on a number of factors including the physical and chemical nature of the drug, the formulation, the type of meal, and the time interval between eating and dosing. Mechanisms of drug-food interactions are not well characterised. They clearly involve both direct and indirect factors in a similar fashion to drug-drug interactions, but indirect factors probably predominate. Reduced or delayed drug absorption is generally attributed, at least in part, to delayed stomach-emptying due to food. Increased absorption may also result from delayed stomach-emptying facilitating greater drug dissolution before it passes from the stomach into the small intestine. Increased bioavailability of some drugs, e.g. propranolol, metoprolol and labetalol, may be related to reduced presystemic clearance. The potential clinical implications of drug-drug and drug-food interactions must be taken into account with oral medications in order to minimise variations in systemic drug availability and hence in clinical efficacy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388952     DOI: 10.2165/00003088-198409050-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  186 in total

1.  Biopharmaceutic influences on the anticholinergic effects of propantheline.

Authors:  M Gibaldi; B Grundhofer
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors:  A Melander; K Danielson; B Scherstén; E Wåhlin
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

3.  Effect of magnesium trisilicate on nitrofurantoin absorption.

Authors:  V F Naggar; S A Khalil
Journal:  Clin Pharmacol Ther       Date:  1979-06       Impact factor: 6.875

4.  Antimicrobial activity and human pharmacology of amoxicillin.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

5.  Blood levels and management of lithium treatment.

Authors:  J L Crammer; R M Rosser; G Crane
Journal:  Br Med J       Date:  1974-09-14

6.  Effect of propantheline and metoclopramide on absorption of digoxin.

Authors:  V Manninen; A Apajalahti; H Simonen; P Reissell
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

7.  Pharmacokinetics of orally administered furosemide.

Authors:  M R Kelly; R E Cutler; A W Forrey; B M Kimpel
Journal:  Clin Pharmacol Ther       Date:  1974-02       Impact factor: 6.875

8.  The influence of cholestyramine on thyroxine absorption.

Authors:  R C Northcutt; J N Stiel; J W Hollifield; E G Stant
Journal:  JAMA       Date:  1969-06-09       Impact factor: 56.272

9.  Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.

Authors:  N H Leeds; P Gal; A A Purohit; J B Walter
Journal:  J Clin Pharmacol       Date:  1982-04       Impact factor: 3.126

10.  Impairing effect of food on ketoconazole absorption.

Authors:  P T Männistö; R Mäntylä; S Nykänen; U Lamminsivu; P Ottoila
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

View more
  44 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

3.  Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.

Authors:  S W Coppack; A F Lant; C S McIntosh; A V Rodgers
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

4.  Milk and yoghurt do not impair the absorption of ofloxacin.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

5.  Inhibition of norfloxacin absorption by dairy products.

Authors:  K T Kivistö; P Ojala-Karlsson; P J Neuvonen
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

6.  The effect of food and metoclopramide on the pharmacokinetics and side effects of bromocriptine.

Authors:  Z Kopitar; B Vrhovac; L Povsic; F Plavsić; I Francetić; J Urbancic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441

7.  The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.

Authors:  C J Betlach; A B Straughn; M C Meyer; M Bialer; V I Vashi; P Liebermann; M A González
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

8.  Pharmacokinetics of diclofenac and misoprostol when administered alone or as a combination product.

Authors:  A Karim
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 9.  Fluoroquinolones: interaction profile during enteral absorption.

Authors:  K M Deppermann; H Lode
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.